News

Home > News & Publications > News > PRISM Biolab and Boehringer Ingelheim enter multi-project drug discovery collaboration

PRISM Biolab and Boehringer Ingelheim enter multi-project drug discovery collaboration

Published on: June 8, 2020

PRISM Biolab provides The PRISM Library, proprietary library of peptide mimetic small molecules for screening against Boehringer Ingelheim’s novel targets

Read Full Press Release

    PRISM is open to all levels of scientific discussion. Our scientists would love to speak with you!

    Scroll to top
    en_USEnglish
    jaJapanese en_USEnglish